{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:52:44Z","timestamp":1780761164026,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Program of Guangzhou","award":["2023A03J0418"],"award-info":[{"award-number":["2023A03J0418"]}]},{"name":"Featured Clinical Technique of Guangzhou","award":["2023C-TS47"],"award-info":[{"award-number":["2023C-TS47"]}]},{"name":"Fund for Clinical Research of the Second Affiliated Hospital of Guangzhou Medical University"},{"name":"Plan on Enhancing Scientific Research in GMU","award":["GMUCR2025-02002"],"award-info":[{"award-number":["GMUCR2025-02002"]}]},{"name":"Guangzhou Medical University Student Innovation Ability Promoting Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04287-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:50:16Z","timestamp":1759161016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Circular RNA profiling and functional analysis implicate circ-ANKRD36C as a potential prognostic biomarker in gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Rongpeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"4287_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534\u201342. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.045.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4287_CR2","doi-asserted-by":"publisher","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study. EClinicalMedicine. 2022;47:101404. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101404.","journal-title":"EClinicalMedicine"},{"key":"4287_CR3","doi-asserted-by":"publisher","first-page":"e12518","DOI":"10.1111\/hel.12518","volume":"23 Suppl 1","author":"M Venerito","year":"2018","unstructured":"Venerito M, Vasapolli R, Rokkas T, Malfertheiner P. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter. 2018;23 Suppl 1:e12518. https:\/\/doi.org\/10.1111\/hel.12518.","journal-title":"Helicobacter"},{"key":"4287_CR4","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s11605-023-05668-y","volume":"27","author":"K Fujikawa","year":"2023","unstructured":"Fujikawa K, Omori T, Shinno N, Hara H, Yamamoto M, Yasui M, et al. Tumor deposit is an independent factor predicting early recurrence and poor prognosis in gastric cancer. J Gastrointest Surg. 2023;27:1336\u201344. https:\/\/doi.org\/10.1007\/s11605-023-05668-y.","journal-title":"J Gastrointest Surg"},{"key":"4287_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.canlet.2017.03.027","volume":"396","author":"J He","year":"2017","unstructured":"He J, Xie Q, Xu H, Li J, Li Y. Circular rnas and cancer. Cancer Lett. 2017;396:138\u201344. https:\/\/doi.org\/10.1016\/j.canlet.2017.03.027.","journal-title":"Cancer Lett"},{"key":"4287_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2018.01.011","volume":"418","author":"B Chen","year":"2018","unstructured":"Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018;418:41\u201350. https:\/\/doi.org\/10.1016\/j.canlet.2018.01.011.","journal-title":"Cancer Lett"},{"key":"4287_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13046-018-1006-x","volume":"37","author":"XN Li","year":"2018","unstructured":"Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL, Yang Y. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018;37:325. https:\/\/doi.org\/10.1186\/s13046-018-1006-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"4287_CR8","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/cam4.1574","volume":"7","author":"L Fu","year":"2018","unstructured":"Fu L, Jiang Z, Li T, Hu Y, Guo J. Circular RNAs in hepatocellular carcinoma: functions and implications. Cancer Med. 2018;7:3101\u20139. https:\/\/doi.org\/10.1002\/cam4.1574.","journal-title":"Cancer Med"},{"key":"4287_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-020-01266-7","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Y, Wang P, Fu X, Lin W. Circular rnas in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy. Mol Cancer. 2020;19:149. https:\/\/doi.org\/10.1186\/s12943-020-01266-7.","journal-title":"Mol Cancer"},{"key":"4287_CR10","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3390\/cancers13133154","volume":"13","author":"G Fontemaggi","year":"2021","unstructured":"Fontemaggi G, Turco C, Esposito G, Di Agostino S. New molecular mechanisms and clinical impact of circRNAs in human cancer. Cancers. 2021;13:3154. https:\/\/doi.org\/10.3390\/cancers13133154.","journal-title":"Cancers"},{"key":"4287_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006.","journal-title":"Cancer Lett"},{"key":"4287_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2019.11.038","volume":"471","author":"J Lu","year":"2019","unstructured":"Lu J, Wang Y, Yoon C, Huang X, Xu Y, Xie J-W, et al. Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis. Cancer Lett. 2019;471:38\u201348. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.038.","journal-title":"Cancer Lett"},{"key":"4287_CR13","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Gla\u017ear","year":"2014","unstructured":"Gla\u017ear P, Papavasileiou P, Rajewsky N. Circbase: a database for circular RNAs. RNA. 2014;20:1666\u201370. https:\/\/doi.org\/10.1261\/rna.043687.113.","journal-title":"RNA"},{"key":"4287_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12859-022-04705-y","volume":"23","author":"S Zhong","year":"2022","unstructured":"Zhong S, Feng J. Circprimer 2.0: a software for annotating circRNAs and predicting translation potential of circRNAs. BMC Bioinformatics. 2022;23:215. https:\/\/doi.org\/10.1186\/s12859-022-04705-y.","journal-title":"BMC Bioinformatics"},{"key":"4287_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.29252\/ibj.23.5.5","volume":"23","author":"A Zare","year":"2019","unstructured":"Zare A, Alipoor B, Omrani MD, Zali MR, MalekpourAlamdari N, Ghaedi H. Decreased miR-155\u20135p, miR-15a, and miR-186 expression in gastric cancer is associated with advanced tumor grade and metastasis. Iran Biomed J. 2019;23:338\u201343. https:\/\/doi.org\/10.29252\/ibj.23.5.5","journal-title":"Iran Biomed J."},{"key":"4287_CR16","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.18632\/oncotarget.7392","volume":"7","author":"C Wu","year":"2016","unstructured":"Wu C, Zheng X, Li X, Fesler A, Hu W, Chen L, et al. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation. Oncotarget. 2016;7:14522\u201336. https:\/\/doi.org\/10.18632\/oncotarget.7392.","journal-title":"Oncotarget"},{"key":"4287_CR17","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366:eaav1741. https:\/\/doi.org\/10.1126\/science.aav1741.","journal-title":"Science"},{"key":"4287_CR18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a\u2013miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14:1271\u20137. https:\/\/doi.org\/10.1038\/nm.1880.","journal-title":"Nat Med"},{"key":"4287_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","volume":"17","author":"RI Aqeilan","year":"2010","unstructured":"Aqeilan RI, Calin GA, Croce CM. MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010;17:215\u201320. https:\/\/doi.org\/10.1038\/cdd.2009.69.","journal-title":"Cell Death Differ"},{"key":"4287_CR20","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.1073\/pnas.1514954112","volume":"112","author":"F Lovat","year":"2015","unstructured":"Lovat F, Fassan M, Gasparini P, Rizzotto L, Cascione L, Pizzi M, et al. MiR-15b\/16-2 deletion promotes B-cell malignancies. Proc Natl Acad Sci U S A. 2015;112:11636\u201341. https:\/\/doi.org\/10.1073\/pnas.1514954112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4287_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","volume":"19","author":"S Guo","year":"2020","unstructured":"Guo S, Fesler A, Huang W, Wang Y, Yang J, Wang X, et al. Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma. Mol Ther. 2020;19:228\u201339. https:\/\/doi.org\/10.1016\/j.omtn.2019.11.010.","journal-title":"Mol Ther"},{"key":"4287_CR22","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.18632\/oncotarget.23414","volume":"9","author":"A Fesler","year":"2017","unstructured":"Fesler A, Liu H, Ju J. Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. Oncotarget. 2017;9:2367\u201383. https:\/\/doi.org\/10.18632\/oncotarget.23414.","journal-title":"Oncotarget"},{"key":"4287_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.12.002","volume":"58","author":"E Arnaiz","year":"2019","unstructured":"Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH. Circrnas and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2018.12.002.","journal-title":"Semin Cancer Biol"},{"key":"4287_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19:188\u2013206. https:\/\/doi.org\/10.1038\/s41571-021-00585-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"4287_CR25","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42:2783\u2013800. https:\/\/doi.org\/10.1038\/s41388-023-02780-w.","journal-title":"Oncogene"},{"key":"4287_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1055\/s-0040-1719030","volume":"121","author":"MK Basu","year":"2021","unstructured":"Basu MK, Massicano F, Yu L, Halkidis K, Pillai V, Cao W, et al. Exome sequencing identifies abnormalities in glycosylation and ANKRD36C in patients with immune-mediated thrombotic thrombocytopenic purpura. Thromb Haemost. 2021;121:506\u201317. https:\/\/doi.org\/10.1055\/s-0040-1719030.","journal-title":"Thromb Haemost"},{"issue":"16_suppl","key":"4287_CR27","doi-asserted-by":"publisher","first-page":"e21517","DOI":"10.1200\/JCO.2022.40.16_suppl.e21517","volume":"40","author":"B Chen","year":"2022","unstructured":"Chen B, Guo S, Xing X, He Q, Zhang Q, Duan Q, et al. Ankrd36 mutation as a negative predictor for melanoma immunotherapy. J Clin Oncol. 2022;40(16_suppl):e21517\u2013e21517. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.e21517","journal-title":"J Clin Oncol"},{"key":"4287_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-015-0323-3","volume":"14","author":"W Kang","year":"2015","unstructured":"Kang W, Tong JH, Lung RW, Dong Y, Zhao J, Liang Q, et al. Targeting of YAP1 by microrna-15a and microrna-16-1 exerts tumor suppressor function in gastric adenocarcinoma. Mol Cancer. 2015;14:52. https:\/\/doi.org\/10.1186\/s12943-015-0323-3.","journal-title":"Mol Cancer"},{"key":"4287_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3892\/or.2017.5673","volume":"38","author":"C Zhao","year":"2017","unstructured":"Zhao C, Li Y, Chen G, Wang F, Shen Z, Zhou R. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3. Oncol Rep. 2017;38:352\u20138. https:\/\/doi.org\/10.3892\/or.2017.5673.","journal-title":"Oncol Rep"},{"key":"4287_CR30","doi-asserted-by":"publisher","unstructured":"Sun Q, Liu H, Guo X, Zhang H, Qin C. Exosomal miR-15b-5p derived from gastric cancer cells enhances immune infiltrating of tumor-associated macrophages through the WIF1\/WNT5A axis. Aging (Albany NY). 2024;13. https:\/\/doi.org\/10.18632\/aging.203192","DOI":"10.18632\/aging.203192"},{"key":"4287_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12672-025-01743-9","volume":"16","author":"A Malviya","year":"2025","unstructured":"Malviya A, Bhuyan R. Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas. Discov Oncol. 2025;16:5. https:\/\/doi.org\/10.1007\/s12672-025-01743-9.","journal-title":"Discov Oncol"},{"key":"4287_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway. Mol Cancer. 2019;18:20. https:\/\/doi.org\/10.1186\/s12943-018-0935-5.","journal-title":"Mol Cancer"},{"key":"4287_CR33","doi-asserted-by":"publisher","first-page":"18277","DOI":"10.1039\/c9ra02230a","volume":"9","author":"Q Li","year":"2019","unstructured":"Li Q, Tang H, Hu F, Qin C. Circular RNA SMARCA5 inhibits gastric cancer progression through targeting the miR-346\/ FBXL2 axis. RSC Adv. 2019;9:18277\u201384. https:\/\/doi.org\/10.1039\/c9ra02230a.","journal-title":"RSC Adv"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04287-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:50:16Z","timestamp":1759161016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4287"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04287-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki () and approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University (approval no. 2023-hs-76r). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"682"}}